BioCentury | Jan 12, 2021
Finance

Jan. 11 Quick Takes: Megarounds for Valo, Visen; plus NuProbe, Sensei

...operations in Houston and Shanghai, raised a $42 million venture round led by BioTrack Capital and Yonghua Capital.Sensei...
BioCentury | Oct 21, 2019
Emerging Company Profile

Verseau unveils tumor macrophage reprogramming strategy

...Alexandria Venture Investments, Highlight Capital, InHarv Partners Ltd., The Mark Foundation for Cancer Research and Yonghua Capital...
BioCentury | Oct 12, 2018
Finance

A Glympse at drug response

...which closed on Oct. 9. Fellow new investors Charles River Ventures, Gilead Sciences Inc. (NASDAQ:GILD), Yonghua Capital...
BioCentury | Oct 11, 2018
Financial News

Polaris, Arch co-lead series A for MIT spinout Glympse

...announced Oct. 9. Also participating were new investors Charles River Ventures, Gilead Sciences Inc. (NASDAQ:GILD), Yonghua Capital...
BioCentury | Oct 9, 2018
Financial News

Polaris, Arch co-lead series A for MIT spinout Glympse

...round, announced Tuesday. Also participating were new investors Charles River Ventures, Gilead Sciences Inc. (NASDAQ:GILD), Yonghua Capital...
BioCentury | Mar 2, 2018
Financial News

Quentis debuts with $48M series A

...and new investor Polaris Partners. New investors AbbVie Ventures, Taiho Pharmaceutical Co. Ltd. (Tokyo, Japan), Yonghua Capital...
BioCentury | Feb 27, 2018
Financial News

Quentis debuts with $48M series A

...and new investor Polaris Partners. New investors AbbVie Ventures, Taiho Pharmaceutical Co. Ltd. (Tokyo, Japan), Yonghua Capital...
BioCentury | Feb 27, 2018
Emerging Company Profile

Stressing out cancer

...Funds raised: $48 million Investors: Versant Ventures, Polaris Partners, AbbVie Ventures, Taiho Pharmaceutical Co. Ltd., Yonghua Capital...
BioCentury | Dec 22, 2017
Financial News

Drug delivery company Taris raises $25M series B

...Lexington, Mass.) raised $25 million in a series B round on Dec. 21 led by Yonghua Capital...
BioCentury | Dec 21, 2017
Financial News

Taris raises $25M series B

...Biomedical LLC (Lexington, Mass.) raised $25 million in a series B round Thursday led by Yonghua Capital...
Items per page:
1 - 10 of 12
BioCentury | Jan 12, 2021
Finance

Jan. 11 Quick Takes: Megarounds for Valo, Visen; plus NuProbe, Sensei

...operations in Houston and Shanghai, raised a $42 million venture round led by BioTrack Capital and Yonghua Capital.Sensei...
BioCentury | Oct 21, 2019
Emerging Company Profile

Verseau unveils tumor macrophage reprogramming strategy

...Alexandria Venture Investments, Highlight Capital, InHarv Partners Ltd., The Mark Foundation for Cancer Research and Yonghua Capital...
BioCentury | Oct 12, 2018
Finance

A Glympse at drug response

...which closed on Oct. 9. Fellow new investors Charles River Ventures, Gilead Sciences Inc. (NASDAQ:GILD), Yonghua Capital...
BioCentury | Oct 11, 2018
Financial News

Polaris, Arch co-lead series A for MIT spinout Glympse

...announced Oct. 9. Also participating were new investors Charles River Ventures, Gilead Sciences Inc. (NASDAQ:GILD), Yonghua Capital...
BioCentury | Oct 9, 2018
Financial News

Polaris, Arch co-lead series A for MIT spinout Glympse

...round, announced Tuesday. Also participating were new investors Charles River Ventures, Gilead Sciences Inc. (NASDAQ:GILD), Yonghua Capital...
BioCentury | Mar 2, 2018
Financial News

Quentis debuts with $48M series A

...and new investor Polaris Partners. New investors AbbVie Ventures, Taiho Pharmaceutical Co. Ltd. (Tokyo, Japan), Yonghua Capital...
BioCentury | Feb 27, 2018
Financial News

Quentis debuts with $48M series A

...and new investor Polaris Partners. New investors AbbVie Ventures, Taiho Pharmaceutical Co. Ltd. (Tokyo, Japan), Yonghua Capital...
BioCentury | Feb 27, 2018
Emerging Company Profile

Stressing out cancer

...Funds raised: $48 million Investors: Versant Ventures, Polaris Partners, AbbVie Ventures, Taiho Pharmaceutical Co. Ltd., Yonghua Capital...
BioCentury | Dec 22, 2017
Financial News

Drug delivery company Taris raises $25M series B

...Lexington, Mass.) raised $25 million in a series B round on Dec. 21 led by Yonghua Capital...
BioCentury | Dec 21, 2017
Financial News

Taris raises $25M series B

...Biomedical LLC (Lexington, Mass.) raised $25 million in a series B round Thursday led by Yonghua Capital...
Items per page:
1 - 10 of 12